Companies / Tango Therapeutics, Inc.
Tango Therapeutics, Inc.
Financials · FY2025
Ownership
168.6M shares outstanding · as of Aug 4, 2026
Ownership
| Insiders | 1.37% | 2,303,673 |
| 10%+ / strategic | 5.03% | 8,477,165 |
| Institutions | 98.73% | 166,471,324 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 5
View all →| Insider | % of shares | Shares |
|---|---|---|
Weber BarbaraDirector, Executive Chair · Director | 0.97% | 1,629,254 |
Peters MalteCEOPresident & CEO · Director | 0.22% | 367,500 |
Beckman DaniellaChief Financial Officer | 0.11% | 184,297 |
Crystal AdamPresident, R&D | 0.07% | 112,622 |
Lee SungDirector | <0.01% | 10,000 |
Institutional holders 179
View all →| Holder | Value | % of shares |
|---|---|---|
| $388.83M | 7.38% | |
| $267.97M | 7.60% | |
| $186.93M | 3.55% | |
| $115.72M | 7.75% | |
| $113.07M | 7.57% | |
| $96.36M | 6.45% | |
| $89.24M | 5.97% | |
| $86.75M | 2.46% | |
| $80.05M | 2.27% | |
| $72.35M | 4.84% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | Crystal Adam Executive | Sell | Common Stock | $694.2K | -54K -29.03% | 132,873 0.08% of shares | medium |
| Feb 3, 2026 | Weber Barbara Executive | Sell | Common Stock | $370.0K | -30K -1.82% | 1,629,587 0.97% of shares | medium |
| Mar 5, 2026 | Crystal Adam Executive | Sell | Common Stock | $303.8K | -20K -15.24% | 112,622 0.07% of shares | medium |
| Mar 25, 2026 | Crystal Adam Executive | Sell | Common Stock | $241.3K | -12K -9.63% | 112,622 0.07% of shares | medium |
| Feb 3, 2026 | Crystal Adam Executive | Sell | Common Stock | $223.7K | -18K -8.87% | 187,419 0.11% of shares | medium |
| Feb 3, 2026 | Beckman Daniella Executive | Sell | Common Stock | $125.1K | -10K -5.24% | 184,410 0.11% of shares | medium |
| Mar 25, 2026 | Crystal Adam Executive | Exercise | Common Stock | $62.4K | +12K +10.66% | 124,622 0.07% of shares | low |
| Feb 3, 2026 | Weber Barbara Executive | Sell | Common Stock | $4.3K | -333 -0.02% | 1,629,254 0.97% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Vanguard Group Inc | Passive13G | — |
| Farallon Capital Partners, L.P. | Passive13G/A | — |
| Adage Capital Management, L.P. | Passive13G | — |
| EcoR1 Capital, LLC | Passive13G/A | — |
| Woodline Partners LP | Passive13G/A | — |
| Invus, L.P. | Passive13G/A | — |
| TCG Crossover GP II, LLC | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| TNGX | — | 87583X109 |